Matthew Gugino appointed CFO of Danaher Corporation

Danaher Corporation has announced the appointment of Matthew Gugino as Chief Financial Officer, effective February 28, 2026. Gugino, who is currently the Group Chief Financial Officer of the Life Sciences Innovations Group, will succeed Matthew McGrew, who will transition to Executive Vice President and begin a gradual retirement after over two decades with the company.

Leadership Transition

President and CEO Rainer Blair acknowledged McGrew's significant contributions to the organization, particularly in strategic acquisitions and growth initiatives. “Matt McGrew's financial leadership over the past two decades has been instrumental in shaping the Danaher you see today,” Blair stated.

Future Outlook

Blair expressed confidence in Gugino's capabilities as the incoming CFO, citing his extensive expertise in financial planning, Mergers and Acquisitions (M&A), and talent development. “Matt has been instrumental in shaping our financial strategy and portfolio evolution,” he added.

Gugino's Background

Joining Danaher in 2013, Gugino has served in various finance leadership positions, including Director of Investor Relations, Vice President of Financial Planning & Analysis from 2019, and Group CFO since 2021. His previous experience includes positions at Barclays and Morgan Stanley, adding to his qualifications in corporate finance.

This announcement highlights a key leadership change within Danaher Corporation, marking a notable transition in its financial management. The summary reflects a factual overview of the new appointment and its implications for the organization.